User profiles for Fernando Valiente-Echeverría

Fernando Valiente-Echeverría

Virology Program, ICBM, Facultad de Medicina, Universidad de Chile
Verified email at uchile.cl
Cited by 2278

[HTML][HTML] Identificación molecular de Ehrlichia canis en un canino de la ciudad de Arica, Chile

…, C Caballero, F Valiente-Echeverría - Revista chilena de …, 2012 - SciELO Chile
vol. 29 número5 Comparación de adenosina deaminasa y detección de anticuerpos anti-antígeno
A60 para el diagnóstico de meningitis tuberculosa Informe: infecciones por …

[HTML][HTML] Identificación morfológica y molecular de filarias caninas en una comuna semi-rural de la Región Metropolitana, Chile

J López, F Valiente-Echeverría, M Carrasco… - Revista chilena de …, 2012 - SciELO Chile
LOPEZ, Javier et al. Identificación morfológica y molecular de filarías caninas en una comuna
semi-rural de la Región Metropolitana, Chile. Rev. chil. infectol.[online]. 2012, vol. 29, n. 3, …

Safety and immunogenicity of an inactivated severe acute respiratory syndrome coronavirus 2 vaccine in a subgroup of healthy adults in Chile

…, A Oyarzún-Arrau, F Valiente-Echeverría… - Clinical Infectious …, 2022 - academic.oup.com
Background The development of effective vaccines against coronavirus disease 2019 is a
global priority. CoronaVac is an inactivated severe acute respiratory syndrome coronavirus 2 (…

Infectivity and immune escape of the new SARS-CoV-2 variant of interest Lambda

…, F Paredes, CP Cortés, F Valiente-Echeverría… - Medrxiv, 2021 - medrxiv.org
Background The newly described SARS-CoV-2 lineage C.37 was recently classified as a
variant of interest by the WHO (Lambda variant) based on its high circulation rates in South …

[HTML][HTML] Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial

…, R Soto-Rifo, F Valiente-Echeverría… - PLoS …, 2021 - journals.plos.org
Background Convalescent plasma (CP), despite limited evidence on its efficacy, is being
widely used as a compassionate therapy for hospitalized patients with COVID-19. We aimed to …

RNA helicase DDX3: at the crossroad of viral replication and antiviral immunity

F ValienteEcheverría, MA Hermoso… - Reviews in medical …, 2015 - Wiley Online Library
Asp‐Glu‐Ala‐Asp (DEAD)‐box polypeptide 3, or DDX3, belongs to the DEAD‐box family of
ATP‐dependent RNA helicases and is known to play different roles in RNA metabolism …

A booster dose of CoronaVac increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concern

…, A Gaete-Argel, ML Acevedo, F Valiente-Echeverría… - MBio, 2022 - Am Soc Microbiol
CoronaVac is an inactivated SARS-CoV-2 vaccine approved by the World Health Organization
(WHO). Previous studies reported increased levels of neutralizing antibodies and specific …

[HTML][HTML] Who regulates whom? An overview of RNA granules and viral infections

…, J Vera-Otarola, R Soto-Rifo, F Valiente-Echeverría - Viruses, 2016 - mdpi.com
After viral infection, host cells respond by mounting an anti-viral stress response in order to
create a hostile atmosphere for viral replication, leading to the shut-off of mRNA translation (…

[HTML][HTML] Anaplasma platys in dogs, Chile

…, P Godoy, A Veloz, F Valiente-Echeverría… - Emerging Infectious …, 2007 - ncbi.nlm.nih.gov
We conducted a 16S rRNA nested PCR for the genus Ehrlichia and Ehrlichia spp. with blood
samples from 30 ill dogs in Chile. Phylogenetic analysis was performed by using groESL …

[HTML][HTML] New challenges of HIV-1 infection: how HIV-1 attacks and resides in the central nervous system

V Rojas-Celis, F Valiente-Echeverría, R Soto-Rifo… - Cells, 2019 - mdpi.com
Acquired immunodeficiency syndrome (AIDS) has become one of the most devastating
pandemics in recorded history. The main causal agent of AIDS is the human immunodeficiency …